Prof. Andrea Alimonti is Director of the Institute of Oncology Research (IOR) in Bellinzona and a leading investigator in prostate cancer resistance biology. His group studies androgen receptor pathway escape, cellular senescence, and the tumour microenvironment. Peptone collaborates with IOR and Prof. Alimonti on AR-NTD mechanism of action and disease biology. (Collaboration)
Director, Institute of Oncology Research